Squawk Pod: Private credit woes & psychedelic wins - 04/20/26 | Audio Only

Key Concepts

• Private Credit: Lending to companies outside of traditional banking; requires careful selection and understanding of liquidity constraints.
• In-Vivo CAR-T Therapy: A method of modifying T-cells directly inside the patient’s body to fight cancer, avoiding the lengthy extraction and re-infusion process.
• AI & Productivity: The debate over whether AI will drive massive productivity gains or cause structural unemployment (20–30%).
• Market Psychology: The tendency for investors to buy when prices rise and sell when they fall, which Howard Marks identifies as the primary obstacle to superior investing.
• Regulatory Hurdles: The tension between FDA approval processes and biotech companies seeking faster pathways for innovative treatments (e.g., psychedelics, cancer vaccines).

1. Market Outlook and Investment Strategy

Howard Marks (Oak Tree Capital) emphasizes that "superior investing" is about exploiting the mistakes of others. He argues that current markets are not "on sale," as the optimism of the last 43 months has driven valuations high.

• Private Credit: Marks notes that while there is nothing inherently wrong with private credit, the risk lies in poor management and selling illiquid products to investors who do not understand the exit limitations.
• Valuation: He suggests that assets should be valued at what an "intelligent, unemotional buyer" would pay, rather than relying on volatile market prices.
• The "Mag 7": Marks views the Magnificent Seven as high-quality companies with reasonable P/E ratios (in the 30s) compared to historical "Nifty Fifty" bubbles (60–90 P/E).

2. AI, Automation, and the Workforce

The panel discussed the potential for AI to cause seismic shifts in the labor market.

• The "Washing Machine" Analogy: One perspective suggests that AI, like household appliances in the past, might free up labor for new, yet-to-be-invented roles.
• Structural Unemployment: Conversely, there is concern that AI could lead to 20–30% unemployment within 2–5 years. The debate centers on whether capitalism can survive such a shift without massive redistribution (e.g., Universal Basic Income).
• Kevin Worsh’s Approach: As a Fed nominee, Worsh is noted for his "tech-forward" perspective, suggesting central bankers must "front-run" technology before it appears in economic data to avoid being behind the curve.

3. Healthcare Innovation

Dr. Scott Gottlieb provided insights into the evolving biotech landscape:

• Cancer Vaccines & CAR-T: Modern cancer vaccines (using mRNA) and in-vivo CAR-T therapies are designed to train the immune system to recognize and attack tumors. These represent a shift from external cell modification to internal genetic modification.
• Psychedelics Regulation: The President’s executive order aims to expedite the FDA approval process for psychedelics (specifically ibogaine) to provide a "rational development process" for veterans, moving these treatments from unregulated clinics into supervised medical settings.
• FDA Friction: There is growing tension between biotech firms and the FDA, with companies alleging that the agency reneges on prior clinical trial guidance, creating uncertainty in the drug development pipeline.

4. Geopolitical and Economic Risks

• US-Iran Tensions: The seizure of an Iranian vessel by the USS Spruance has heightened tensions. While markets have largely "shrugged off" the conflict, there is concern regarding the economic fallout for Middle Eastern allies, with discussions of potential US-led "sovereign bridge loans" or currency swaps to prevent regional economic collapse.

5. Notable Quotes

• Howard Marks: "If you want to be a superior investor, your job can be reduced to: I want to take advantage of the mistakes that other people make."
• Howard Marks: "There is nothing so injurious to your mental well-being as to watch a friend get rich."
• Dr. Scott Gottlieb: "The technology around cancer vaccines... we've been working on these for probably three decades now."

Synthesis

The video highlights a period of transition characterized by high market valuations, rapid technological disruption, and geopolitical instability. The core takeaway is the necessity of maintaining emotional discipline in investing—avoiding the "hot potato" game of chasing trends—while acknowledging that structural changes in AI and medicine are moving faster than traditional regulatory and economic frameworks can adapt. The consensus among the experts is that while innovation (AI, biotech) offers immense long-term potential, the short-term risks of market volatility and labor displacement require proactive, rather than reactive, policy and investment management.